CSPC Pharmaceutical Announces 2018 Annual Results
Profit Attributable To Shareholders Increased 31.9% to HK$3,655 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Deployment Further Improved HONG KONG, March 18, 2019 /PRNewswire/ — CSPC Pharmaceutical…